ArticleCancer causes & control : CCC2026
Impact of psychiatric disorders on treatment adherence and overall survival in patients with Hodgkin lymphoma: a retrospective cohort study.
Article in Cancer causes & control : CCC, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPsychiatric comorbidities are common in patients with Hodgkin lymphoma (HL) and may influence treatment adherence and survival outcomes. This study aimed to evaluate the impact of psychiatric disorders on overall survival and treatment adherence in HL patients.
methodsA retrospective cohort study was conducted including 139 HL patients treated at the General Hospital of Mexico "Dr Eduardo Liceaga." Clinical, demographic, and psychiatric data were collected. Overall survival was analyzed using Kaplan-Meier curves and Cox proportional hazards models adjusted for Ann Arbor stage, treatment adherence, and psychiatric disorders. Treatment adherence was assessed, and its association with survival was explored using time-varying hazard ratios.
findingsAmong 139 patients, those with psychiatric disorders exhibited significantly worse overall survival (HR 6.80, 95% CI 1.32-34.95, p = 0.022). Adherence to treatment was independently associated with improved survival (HR 0.05, 95% CI 0.02-0.16, p < 0.001). Time-varying analysis showed the highest hazard ratio for psychiatric disorders during the early follow-up period.
conclusionPsychiatric disorders are independently associated with poorer overall survival in patients with Hodgkin lymphoma, partly mediated by reduced treatment adherence. Early recognition and integrated psychosocial interventions may improve treatment continuity and survival outcomes.
Indexed as
Identifiers
41546839What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.